Projects per year
Personal profile
Education
- 2005 Ph.D. (Anatomy and Cell Biology), Queen's University, Kingston, Ontario, Canada
- 1997 B.S.(Biochemistry), Queen's University, Kingston, Ontario, Canada
Experience
- 2019- Associate Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University
-
2013- Associate Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2012-2013 Assistant Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2008-2012 Assoistant Professor, Department of Radiology, Taipei Medical University
- 2010 Visiting scholar to Dr. Andrew Kung’s lab at Dana Farber Cancer Institute
Research Interests
- Cancer/stem cell biology
- Translational research
- New drug/therapeutic strategy development
- Regenerative medicine
- Biology and applications of extracellular vesicles
Related Link
Fingerprint
Dive into the research topics where Alexander Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Translational Exploration of Anisomelic Acid'S Potential in Reprogramming Tumor Immune Microenvironment (Time) via Regulating Exosomal Biogenesis to Overcome Immune Checkpoint Inhibitor (Ici) Resistance Mediated by Head and Neck Cancer Stem Cells
Wu, A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Leveraging Cardiac Protective Peptides (Cpps) to Augment Msc-Derived Small Extracellular Vesicles Potentials for Precision Myocardial Infarction Therapy and Prevention( I )
Wu, A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(3/3)
Wu, A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Exploration of Anisomelic Acid'S Potential in Reprogramming Tumor Immune Microenvironment (Time) to Overcome Immune Checkpoint Inhibitor (Ici) Resistance Mediated by Head and Neck Cancer Stem Cells
Wu, A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(2/3)
Wu, A. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration
Kuo, Y. C., Lawal, B., Lukman, H. Y., Chen, L. C., Huang, S. L., Chen, Y. F., Fadaka, A. O., Olawale, F., Olasupo, A., Ajenifujah, O. T., Fouad, D., Papadakis, M., Batiha, G. E. S., Sabiu, S., Wu, A. T. H. & Huang, H. S., 2025, In: International Journal of Medical Sciences. 22, 8, p. 1837-1851 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60
Tang, S. L., Sumitra, M. R., Kuo, Y. C., Hsu, H. L., Ansar, M., Huang, S. L., Lee, S. Y., Wang, H. J., Lawal, B., Wu, A. T. H., Chen, L. C. & Huang, H. S., Jul 2025, In: Computers in Biology and Medicine. 193, 110445.Research output: Contribution to journal › Article › peer-review
-
In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential
Huynh, H. T. L. K., Lim, H. G. M., Lee, Y. C. G., Phan, T. V., Vo, T. H., Chen, C. H. & Wu, A. T. H., 2025, In: International Journal of Medical Sciences. 22, 8, p. 1885-1904 20 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer
Chen, J. S., Enwolo-Chibueze, C. G., Chinyama, H. A., Lai, C. T., Ezeala, I. C., Huang, P. Y., Wu, A. T. H. & Huang, Y. J., Sept 2025, In: International journal of molecular sciences. 26, 18, 8780.Research output: Contribution to journal › Article › peer-review
Open Access -
Machine learning–driven discovery of NSC828779 as a multi-mechanistic NLRP3 inflammasome inhibitor for inflammatory diseases
Tang, S. L., Sumitra, M. R., Chen, L. C., Liu, F. C., Hsu, H. L., Kuo, Y. C., Ansar, M., Huang, S. L., Lee, S. Y., Wang, H. J., Lawal, B., Wu, A. T. H., Wen, Y. T. & Huang, H. S., Oct 2025, In: Computers in Biology and Medicine. 197, 111110.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Wu, A. T. H. (Creator), Yeung, S.-C. J. (Contributor), Wen, K.-C. (Creator), Chou, P.-C. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor) & Sung, P.-L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
Dataset
-
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Chou, P.-C. (Contributor), Wen, K.-C. (Creator), Lee, M.-H. (Contributor), Lin, J.-H. (Contributor), Sung, P.-L. (Contributor), Yeung, S.-C. J. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://doi.org/10.6084%2Fm9.figshare.12845525.v1
Dataset